BioMarin Pharmaceutical Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMRN Nasdaq 2834 http://www.bmrn.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioMarin Pharmaceutical Inc.

Ascendis' Dwarfism Candidate Gets Orphan Drug Status in EU - Aug 13th, 2020 4:48 pm
European Medicines Agency Validates BioMarin's Marketing Authorization Application for Vosoritide to Treat Children with Achondroplasia - Aug 13th, 2020 12:31 pm
BioMarin to Participate in Two Upcoming Virtual Investor Conferences - Aug 10th, 2020 12:30 pm
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year? - Aug 7th, 2020 3:30 pm
BioMarin (BMRN) Q2 Earnings Top, Sales Show Coronavirus Impact - Aug 5th, 2020 3:57 pm
How Biomarin Beat Expectations in Q2 - Aug 5th, 2020 10:35 am
Biomarin Pharmaceutical Inc (BMRN) Q2 2020 Earnings Call Transcript - Aug 5th, 2020 6:01 am
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Beat Estimates - Aug 4th, 2020 9:35 pm
Lion Biotechnologies Reaches 80-Plus Relative Strength Rating Benchmark - Aug 4th, 2020 9:33 pm
BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million - Aug 4th, 2020 8:05 pm
Composite Rating For Emergent Biosolutions Rises To 99 - Aug 3rd, 2020 10:27 pm
Biomarin Pharmaceutical's Earnings: A Preview - Aug 3rd, 2020 4:29 pm
BioMarin (BMRN) to Report Q2 Earnings: What's in the Cards? - Jul 31st, 2020 1:55 pm
10 Biggest Biotechnology Companies - Jul 30th, 2020 11:32 pm
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth - Jul 28th, 2020 4:33 pm
3 Unstoppable Stocks to Buy Before the Next Market Crash - Jul 25th, 2020 11:30 am
3 Biotech Stocks With Big Incoming Catalysts - Jul 25th, 2020 10:56 am
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs - Jul 24th, 2020 11:15 am
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Vosoritide to Treat Children with Achondroplasia - Jul 23rd, 2020 8:07 pm
BioMarin to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 4 at 4:30pm ET - Jul 21st, 2020 12:30 pm